Back to Screener

Financial Services

BondBloxx BBB Rated 1-5 Year Corporate Bond ETF(BBBS)

Live Price

Offline

$51.05

+0.09% today

1Y Change

-0.58%

Window

Jun 25, 2025 โ†’ Jun 18, 2026

Market Cap
$160.00M
Revenue Growth
0.0%
EPS Growth
0.0%
Dividend Yield
0.0%

Coverage: 247 bars ยท Jun 25, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

BondBloxx BBB Rated 1-5 Year Corporate Bond ETF (BBBS) is a Financial Services stock with a market cap of $160.00M. The stock last traded around $51.05 and down 0.6% across the available one-year price window (Jun 25, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Stock Foundry combines BBBS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Benchmark Edge

BBBS vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BBBS

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BBBS Max Drawdown

-2.00%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BBBS and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

BondBloxx BBB Rated 1-5 Year Corporate Bond ETF (BBBS)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

Latest Revenue

โ€”

Latest Net Income

โ€”

Free Cash Flow

โ€”

Revenue Growth

+0.0%

EPS Growth

+0.0%

Gross Margin

0.0%

Net Margin

0.0%

No financial statement data available for BBBS in annual view.

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.